Ascendis Pharma competitive analysis

Explore patent oppositions filed by Ascendis Pharma against competitors, revealing strategic technology disputes and market positioning.

Last updated on: Jan 22, 2026
Patent NumberTitleApplicantOpposition Date
Variants Of C-Type Natriuretic PeptideBIOMARIN PHARMACEUTICALApr 10, 2025
Variants Of C-Type Natriuretic PeptideBIOMARIN PHARMACEUTICALSep 1, 2022

Latest PTAB cases involving Ascendis Pharma

Discover the latest PTAB cases involving Ascendis Pharma, highlighting their recent legal challenges and patent disputes.

Last updated on: Jan 23, 2026
Proceeding NumberFiling DatePetitionerRespondentStatus

Get alerts for PTAB Cases involving Ascendis Pharma

PGR2026-00013Nov 24, 2025ASCENDIS PHARMABIOMARIN PHARMACEUTICALPending

Peer Comparison New

IP litigation analysis comparing Ascendis Pharma with top 3 competitors. Includes complete PTAB case data and opposition data from 2018 onwards.

Last updated on: Jan 22, 2026
CompanyOppositions FiledOppositions FacedPTAB Cases FiledPTAB Cases Faced
ASCENDIS PHARMA GROWTH DISORDERS1 - - -
BIOMARIN PHARMACEUTICAL - 1831